Jaspreet Dhillon

TAFRO syndrome: A case report and review of the literature.

E. Jaffe, G. Deeb, N. Zhang, 2017, Human pathology.

Y-BOX BINDING PROTEIN-1 IS ESSENTIAL FOR THE GROWTH AND SURVIVAL OF HER2 OVER-EXPRESSING BREAST CANCERS AND MEDIATES TRASTUZUMAB RESISTANCE BY INDUCING CD44

Jaspreet Dhillon, 2010 .

Resistance to angiogenesis inhibitors in renal cell carcinoma.

R. Pili, I. Tamaskar, Jaspreet Dhillon, 2011, Clinical advances in hematology & oncology : H&O.

Molecular Decoy to the Y-Box Binding Protein-1 Suppresses the Growth of Breast and Prostate Cancer Cells whilst Sparing Normal Cell Viability

M. Gleave, Steven J. M. Jones, C. Eaves, 2010, PloS one.

Mediastinal staging of non-small-cell lung cancer

S. Yendamuri, S. Dhillon, Jaspreet Dhillon, 2011, Expert review of respiratory medicine.

Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice.

C. Eaves, M. Hung, A. Astanehe, 2008, Cancer research.

Suppresses Tumor Growth in Mice Cells Induces Apoptosis via the mTOR / STAT 3 Pathway and Targeting YB-1 in HER-2 Overexpressing Breast Cancer

C. Eaves, M. Hung, A. Astanehe, 2008 .

The expression of activated Y-box binding protein-1 serine 102 mediates trastuzumab resistance in breast cancer cells by increasing CD44+ cells

A. Astanehe, S. Dunn, A. Fotovati, 2010, Oncogene.

MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition

M. Krzywinski, G. Mills, M. Marra, 2012, Oncogene.